June 12, 2009 FDA Clears Hologic R2™ DIGITALNOW™ HD Software Application Hologic today announced that it has received Food and Drug Administration (FDA) clearance for its R2™ DigitalNow™ HD software application. | May 20, 2009 Hologic To Present At Two Investor Healthcare ConferencesHologic today announced that Glenn Muir, Chief Financial Officer, will present at the 8th Annual Needham Life Sciences Conference in New York on Wednesday, June 10, 2009 at 3:00 p.m. (Eastern) and the Jefferies 3rd Annual Healthcare Conference in New York on Wednesday, June 17, 2009 at 4:15 p.m. (Eastern). | March 17, 2009 Hologic to Release Second Quarter Fiscal 2009 Operating Results on Monday, May 4, 2009Hologic today announced plans to release its second quarter fiscal 2009 operating results on Monday, May 4, 2009 after market close. In conjunction with the release, management will host a conference call on Monday, May 4, 2009 at 5:00 p.m. (eastern). | March 13, 2009 FDA Approves Two Hologic HPV TestsHologic today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's premarket approval (PMA) applications for both the Cervista HPV HR (high risk) and the Cervista HPV 16/18 tests. | March 05, 2009 Hologic Through Tromp Medical is Awarded 100 Percent of the Digital Mammography Systems Under The Netherlands Breast Cancer Screening TenderHologic today announced that it has received a final order for 14 Selenia™ digital mammography systems with service contracts from Tromp Medical, the Hologic dealer in The Netherlands. | February 09, 2009 Hologic To Present At The Raymond James 30th Annual Institutional Investors ConferenceHologic today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Raymond James 30th Annual Institutional Investors Conference being held March 9, 2009 at the JW Marriott Grande Lakes hotel in Orlando, FL.
| January 12, 2009 Hologic to Provide Business Update at Investor Meeting Reports Preliminary Fiscal First Quarter Revenues Below Expectations and EPS and Adjusted EPS In-Line as Hospital Spending TightensHologic today is announcing preliminary unaudited first quarter fiscal 2009 revenues and earnings per diluted share (EPS) in conjunction with a presentation by Hologic’s Chairman and Chief Executive Officer, Jack Cumming, at the J.P. Morgan 27th Annual Healthcare conference today, Monday, January 12, 2009, in San Francisco, CA, at 1:30 p.m. Pacific Time/4:30 p.m. Eastern Time. | January 06, 2009 Hologic Receives CE Marking for Adiana® Permanent Contraception SystemHologic today announced that it has received CE marking approval for its Adiana® permanent contraception system. The Adiana system is designed to provide a minimally-invasive, non-incisional alternative to traditional, surgical means of female sterilization. |
|
